Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
08 May, 2026, 12.50 PM IST
Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
03 May, 2026, 12.42 AM IST
Aurobindo unit terminates pact with Singapore firm to develop pentavalent vaccineAurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for developing a pentav...
05 Mar, 2025, 03.37 PM IST
USFDA flags Telangana unit of Aurobindo Pharma armThe letter, issued on August 15, was later made public by the USFDA, which stated that there was failure to ensure the accuracy of data in ...
22 Aug, 2024, 01.01 AM IST
Aurobindo Pharma signs pact with MSD to supply biologicals, to invest Rs.1000 crore on plantAurobindo Pharma's subsidiary, TheraNym Biologics Pvt Ltd, has signed a master service agreement with Merck Sharpe & Dohme Singapore for co...
31 May, 2024, 08.12 PM IST
Director's arrest no way linked to operations: Aurobindo Pharma"Further to the disclosure of even date, the company further learnt that the arrest of P Sarath Chandra Reddy, whole-time director/promoter...
10 Nov, 2022, 06.58 PM IST
Aurobindo Pharma arm's New Jersey unit gets warning letter from USFDAThis follows the earlier letter dated June 4, 2020, issuing an OAI (Official Action Indicated) status for this facility.
22 Oct, 2020, 10.55 AM IST
Aurobindo, Sandoz call off USD 900 mn dealThe transaction if completed would have positioned the Hyderabad-based firm as the second largest dermatology player and the second largest...
02 Apr, 2020, 01.43 PM IST
Aurobindo Pharma says co, subsidiary made party to litigation proceeding in USThe drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless alle...
07 Jun, 2019, 02.25 PM IST
Aurobindo Pharma arm enters pact to form JV in China with Luoxin"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharm...
11 Dec, 2018, 05.48 PM IST
Aurobindo Pharma inks pact to acquire Australian pharma firm's productBased out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets.
13 Nov, 2018, 02.35 PM IST
Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mnThe acquisition is for a cash consideration of USD 12.5 million, it added. The indicative time period for completion of the acquisition is ...
12 Nov, 2018, 10.36 PM IST
Aurobindo divests Australian arm to Eris PharmaAPL will continue to manufacture and supply products to Eris Pharma for Australian and New Zealand markets over the next few years.
10 Apr, 2015, 01.33 PM IST
- Aurobindo: Proceeds from stake sale to beef up cash flows
From being a low-margin pharma manufacturer, Aurobindo Pharma is transforming itself into a high-margin formulations player.
12 Jan, 2011, 06.08 AM IST
- Aurobindo to divest stake in China arm
Generic drugmaker Aurobindo Pharma has decided to divest its stake in loss-making Chinese subsidiary , Aurobindo (Datong) Bio Pharma (ADBPL...
12 Jan, 2011, 05.55 AM IST
- Aurobindo’s Chinese gamble may pay off
After three consecutive years of loss, Aurobindo Pharma is cutting loose its bleeding Chinese pharma subsidiary Aurobindo Tongling, while s...
17 Nov, 2006, 12.25 AM IST
- Aurobindo Pharma to divest Chinese arm
Hyderabad-based Aurobindo Pharma has decided to disinvest its loss-making subsidiary in China while acquiring a small manufacturing unit in...
15 Nov, 2006, 07.00 PM IST